Cutler Group LP Standard Biotools Inc. Call Options Transaction History

Cutler Group LP

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2021 Oct 26, 2021	BUY	$5.5 - $7.41 $3,300 - $4,446	600 Added 75.0%	1,400 $0
Q2 2021 Jul 19, 2021	SELL	$4.35 - $6.35 $30,884 - $45,085	-7,100 Reduced 89.87%	800 $0
Q1 2021 Apr 26, 2021	SELL	$3.94 - $7.09 $18,912 - $34,032	-4,800 Reduced 37.8%	7,900 $1,000
Q4 2020 Jan 21, 2021	SELL	$5.45 - $8.65 $461,070 - $731,790	-84,600 Reduced 86.95%	12,700 $5,000
Q3 2020 Oct 27, 2020	BUY	$4.34 - $11.43 $422,282 - $1.11 Million	97,300 New	97,300 $27,000

143

279M

27.2K

34.1K

Ticker LAB
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 78,654,800
Market Cap $131M
Description
Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.